AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 287: E871-E877, 2004. First published July 20, 2004; doi:10.1152/ajpendo.00125.2004
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/E871    most recent
00125.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shearer, J.
Right arrow Articles by Wasserman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shearer, J.
Right arrow Articles by Wasserman, D. H.

AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo

Jane Shearer,1 Patrick T. Fueger,1 Jeffrey N. Rottman,2 Deanna P. Bracy,1 Paul H. Martin,4 and David H. Wasserman1,3

Departments of 1Molecular Physiology and Biophysics, 2Cardiology, 3Diabetes Research and Training Center, and 4Environmental and Civil Engineering, Vanderbilt University, Nashville, Tennessee 37232-0615

Submitted 15 March 2004 ; accepted in final form 2 July 2004

AMP-activated protein kinase (AMPK) independently increases glucose and long-chain fatty acid (LCFA) utilization in isolated cardiac muscle preparations. Recent studies indicate this may be due to AMPK-induced phosphorylation and activation of nitric oxide synthase (NOS). Given this, the aim of the present study was to assess the effects of AMPK stimulation by 5-aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside (AICAR; 10 mg·kg–1·min–1) on glucose and LCFA utilization in cardiac muscle and to determine the NOS dependence of any observed effects. Catheters were chronically implanted in a carotid artery and jugular vein of Sprague-Dawley rats. After 4 days of recovery, conscious, unrestrained rats were given either water or water containing 1 mg/ml nitro-L-arginine methyl ester (L-NAME) for 2.5 days. After an overnight fast, rats underwent one of four protocols: saline, AICAR, AICAR + L-NAME, or AICAR + Intralipid (20%, 0.02 ml·kg–1·min–1). Glucose was clamped at ~6.5 mM in all groups, and an intravenous bolus of 2-deoxy-[3H]glucose and [125I]-15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid was administered to obtain indexes of glucose and LCFA uptake and clearance. Despite AMPK activation, as evidenced by acetyl-CoA carboxylase (Ser221) and AMPK phosphorylation (Thr172), AICAR increased cardiac LCFA but not glucose clearance. L-NAME + AICAR established that this effect was not due to NOS activation, and AICAR + Intralipid showed that increased cardiac LCFA clearance was not LCFA-concentration dependent. These results demonstrate that, in vivo, AMPK stimulation increases LCFA but not glucose clearance by a NOS-independent mechanism.

substrate; lipid; carbohydrate; heart; interaction; AMP-activated protein kinase; long-chain fatty acid



Address for reprint requests and other correspondence: D. Wasserman, Dept. of Molecular Physiology and Biophysics, 823 Light Hall, Vanderbilt University, Nashville, TN 37232-0615 (E-mail: david.wasserman{at}vanderbilt.edu)




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Iiyori, L. C. Alonso, J. Li, M. H. Sanders, A. Garcia-Ocana, R. M. O'Doherty, V. Y. Polotsky, and C. P. O'Donnell
Intermittent Hypoxia Causes Insulin Resistance in Lean Mice Independent of Autonomic Activity
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 851 - 857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan
p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1978 - H1985.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Arad, C. E. Seidman, and J.G. Seidman
AMP-Activated Protein Kinase in the Heart: Role During Health and Disease
Circ. Res., March 2, 2007; 100(4): 474 - 488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan
Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5'-AMP-activated protein kinase
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1883 - H1892.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.